NRC Health (NRC) Q3 2026 earnings review
NRC Health sales jump 11%, but service costs cut margins
NRC Health, a provider of patient-survey software for hospitals, turned its recent contract wins into double-digit sales growth while its underlying profit margins slipped. Revenue rose 11% from a year ago as a major hospital client went live on schedule, chief executive Trent Green said. However, the direct cost of servicing clients jumped 24%, so profit per share excluding one-offs fell from a year ago.
| Revenue | $38.4M +11% from a year ago |
|---|---|
| Total recurring contract value | $154.1M +9% from a year ago |
| Profit per share, excluding one-offs | $0.21 $0.23 a year ago |
| Quarterly dividend outlook | Unchanged $0.16 per share declared |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because the long-awaited revenue acceleration arrived with higher delivery costs and heavier debt. Bringing the largest customer in the company's history live lifted sales growth from 4% last quarter, proving that contract backlog converts into revenue. The bad news: servicing the bigger client base took a larger share of sales, and the company borrowed $15 million to fund share buybacks, pushing shareholder equity below zero.
The question now is whether the jump in direct service costs and unpaid bills was a one-time setup burden for the new hospital client or the new baseline. If it was setup work, gross margin and cash collections will rebound; if the contract carries lower pricing, profit will keep lagging sales. Fourth-quarter direct expenses and receivables will tell.
🐂 Bull Case
New Contracts Finally Lifted Revenue Growth to 11%
NRC Health sells patient-survey and experience software to hospitals, and it tracks demand through Total Recurring Contract Value (TRCV), the yearly value of active customer contracts. In the first quarter, chief executive Trent Green signed the largest contract in the firm's 45-year history, pushing TRCV up 13% from a year ago while revenue rose only 4%.
That gap closed in the third quarter because the hospital client started using the service. "Our large customer went live on schedule, and several long-standing customers renewed under multi-year agreements, reinforcing the durability of our recurring-revenue base," Green said. Revenue rose 11.0% from a year ago to $38.4 million, while TRCV added $2.2 million from last quarter to reach $154.1 million.
What to watch: net new TRCV in the fourth quarter. Because TRCV growth slowed from 13% in the first quarter to 8.8% this quarter, the company needs fresh contract wins to keep revenue growing near 10% next year.
Overhead Restraint Kept Operating Margin Moving Up
Over the past year, executive turnover weighed on reported profit. During the first half of 2026, NRC Health recorded $3.2 million in management transition costs for "bonuses paid to certain executives to cover anticipated tax obligations in connection with amendments to their 2025 equity awards" and "severance costs incurred in connection with team restructurings implemented by newly appointed executives".
In the third quarter, the Nebraska-based provider recorded zero transition charges and cut selling, general and administrative overhead to 31.4% of revenue, down 4.1 percentage points from a year ago by our math. Because overhead fell, operating margin rose 0.8 percentage points from a year ago to 23.2%.
What to watch: selling, general and administrative expenses in the fourth quarter. Staying near $12 million would confirm that the executive restructuring has permanently lowered overhead.
🐻 Bear Case
Higher Direct Service Costs Cut Into Profit Margins
"As our expanding contract base converts into revenue, the operating leverage inherent in our model will translate into greater profitability and free cash flow over time," chief executive Trent Green said. Operating leverage means revenue grows faster than the cost of delivering the service, so profit margins widen against the prior year.
The third-quarter numbers show the opposite against a year ago. Direct operating expenses, the cost of servicing hospital clients and running surveys, rose 24.0% from a year ago to $15.4 million, climbing 4.2 percentage points of revenue by our math.
- Gross margin: 60.0% of revenue, down 4.2 percentage points from a year ago by our math
- Adjusted EBITDA (earnings before interest, taxes, depreciation, amortization and stock pay): $10.9 million, or 28.3% of revenue, down 3.1 percentage points from a year ago
- Profit per share excluding one-offs: $0.21, down from $0.23 a year ago
What to watch: direct operating expenses as a share of revenue in the fourth quarter. A reading above 40% would show that servicing the new large contract carries permanently lower margins.
Borrowing to Fund Buybacks Pushed Shareholder Equity Negative
NRC Health returns cash to shareholders through a $0.16 quarterly dividend and share buybacks. In the third quarter, the healthcare research firm spent $16.0 million repurchasing its own stock and $3.5 million on dividends, while its operations generated $7.0 million in free cash flow.
To cover the $12.5 million gap by our math, the company borrowed $15.0 million on its term notes. That borrowing lifted total debt by 28.6% from a year ago to $102.9 million, while cash stood at $3.6 million. Because treasury stock buybacks subtract from book value, total shareholders' equity fell from $6.5 million in June to negative $9.1 million.
What to watch: fourth-quarter share repurchases and net debt. Further debt-funded buybacks would increase interest expense, which already rose 4.9% from a year ago to $1.5 million this quarter.
Unpaid Customer Bills Cut Operating Cash Flow
When NRC Health bills hospital clients for annual subscriptions, the billed amount sits in accounts receivable until the customer pays cash. In the third quarter, accounts receivable rose by $6.0 million to $15.3 million, up 20.3% from a year ago by our math against an 11.0% rise in revenue.
Because that cash had not arrived by quarter-end, operating cash flow fell 41.7% from a year ago to $8.0 million. Even after cutting capital spending by 71.1%, free cash flow dropped 31.4% to $7.0 million.
What to watch: fourth-quarter accounts receivable and operating cash flow. If the third-quarter spike came from billing the new large customer upon go-live, fourth-quarter collections should bring receivables back near $11 million.
💲 Other KPIs
Deferred revenue — payments billed or collected for subscription services not yet delivered — rose 13.8% from a year ago by our math, accelerating from earlier in the year. The balance jumped by $3.6 million from the second quarter as multi-year renewals and the large hospital contract entered the billing cycle.
Spending on property and equipment fell 71.1% from a year ago by our math, dropping from 10.4% of revenue to 2.7%. Over the first nine months of 2026, capital spending totaled $4.2 million against $9.6 million in the same period last year, cushioning the drop in operating cash flow.
Actual shares outstanding at the end of September fell 6.3% from the end of 2025 by our math after the firm spent $25.6 million on buybacks over the first nine months. Because most third-quarter buybacks happened late in the period, the quarterly average diluted share count fell only 1.1% from a year ago to 21.9 million.
🔮 Guidance
Unchanged. The board declared a $0.16 per share quarterly cash dividend payable in January 2027, keeping the payout level set a year ago. NRC Health does not issue numerical revenue or profit forecasts, pointing instead to its $154.1 million recurring contract base as its indicator for the next 12 months.
❓ Key Questions
Why did direct service costs jump 24% this quarter?
Direct operating expenses rose by $3.0 million from a year ago, faster than the $3.8 million rise in revenue. Investors need to know if this reflects one-time setup work for the large hospital client or permanently lower contract margins.
Why did NRC Health borrow money to buy back shares?
The company borrowed $15 million on its term notes while spending $16 million on stock buybacks, pushing total debt to $102.9 million and shareholder equity below zero. Management has not stated a debt limit.
What caused the $6 million spike in unpaid customer bills?
Accounts receivable jumped from $9.3 million in June to $15.3 million in September, cutting operating cash flow by 42% from a year ago. Management should clarify whether this reflects normal annual billing for the new contract or slower hospital payments.
Can contract growth re-accelerate after slowing for two quarters?
Total recurring contract value growth stepped down from 13% in the first quarter to 11% in the second and 9% in the third. Without new large hospital wins, revenue growth will slow once the current contract base laps next year.